A low viral load suggests controlled infection or effective treatment response, but continued monitoring is necessary to ensure the virus does not reactivate.

It is commonly ordered for transplant patients, individuals with weakened immune systems, pregnant women, and newborns suspected of congenital CMV infection.

Certainly, it is used to detect CMV DNA in newborns, confirming congenital infection and guiding early treatment to prevent long-term complications.

Yes, repeated testing helps track changes in viral load, showing whether antiviral therapy is successfully reducing CMV levels in the patient’s blood.

A negative result usually means no detectable CMV DNA, but doctors may repeat testing if symptoms persist or risk factors remain high.